{
    "clinical_study": {
        "@rank": "10029", 
        "arm_group": {
            "arm_group_label": "miRNA", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The goal of this study is to demonstrate the sensitivity and specificity of detecting\n      circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow\n      expression and modulation of levels in response to therapy in comparison to current\n      biomarkers."
        }, 
        "brief_title": "Modulation of Molecular Fingerprinting in Pediatric Sepsis", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Systemic Inflammatory Response Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Systemic Inflammatory Response Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will aid in the evaluation of determining the accuracy of these miRNAs in\n      pediatric patients and help in establishing pilot data for additional studies in the future.\n      The testing will include blood samples, urine samples and buccal swabs from patients who\n      meet eligibility at 5 time points to analyze biomarkers. Study participants will receive\n      standard of care with antimicrobials and any additional appropriate cardiovascular or\n      respiratory support per the clinical team. The samples will collected and stored at -80\n      until analysis can be performed. In addition to, during the course of the hospitalization,\n      the enrolled patient will have data collected to calculate severity scores, including\n      updated Pediatric Risk of Mortality (PRISM III) scores and simplified Therapeutic\n      Intervention Scoring System(TISS-28) scores. All patient information will be de-identified.\n      A standard procedure manual will be developed detailing the methods for data collection and\n      entry. Data will be recorded in a de-identified manner on a Microsoft Excel database on a\n      secure institutional server by the institutional staff. Data will then be analyzed to\n      determine correlation of biomarkers to morbidity and mortality for these patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 1 through 18 years\n\n          -  Patients admitted to the PICU with concerns for sepsis or those developing sepsis\n             during their admission to the hospital.\n\n          -  Patients must be enrolled int he study from arrival time tot he ED up to 24 hours\n             from the time of initiation of antibiotic therapy for treatment of sepsis or septic\n             shock.\n\n          -  Signed informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients <1 year of age and greater than 18 years of age."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02055105", 
            "org_study_id": "PHNX-biosep-12159"
        }, 
        "intervention": {
            "arm_group_label": "miRNA", 
            "description": "miRNA in Sepsis", 
            "intervention_name": "miRNA in Sepsis", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Pediatric Sepsis", 
        "lastchanged_date": "February 3, 2014", 
        "location": {
            "contact": {
                "email": "amisra@phoenixchildrens.com", 
                "last_name": "Amit Misra, MD", 
                "phone": "602-933-1784"
            }, 
            "facility": {
                "address": {
                    "city": "Phoenix", 
                    "country": "United States", 
                    "state": "Arizona", 
                    "zip": "85019"
                }, 
                "name": "Phoenix Children's Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Modulation of Molecular Fingerprinting in Pediatric Sepsis", 
        "overall_contact": {
            "email": "amisra@phoenixchildrens.com", 
            "last_name": "Amit Misra, MD", 
            "phone": "6029331784"
        }, 
        "overall_contact_backup": {
            "email": "hdalton@phoenixchildrens.com", 
            "last_name": "Heidi J Dalton, MD", 
            "phone": "6029331784"
        }, 
        "overall_official": {
            "affiliation": "Phoenix Children's Hospital", 
            "last_name": "Amit Misra, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Phoenix Children's Hospital Institutional Review Board", 
                "United States: Center for Applied Nanobioscience and Medicine", 
                "United States: The Research Institute at Nationwide Children's Hospital"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Will compare PRISM 3 scores from baseline to hospital discharge.", 
            "measure": "Risk of Mortality", 
            "safety_issue": "No", 
            "time_frame": "Duration of hospital stay, an expected average of 3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02055105"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Will compare sequential organ failure assessment (SOFA) scores throughout hospitalization.", 
                "measure": "Organ Failure", 
                "safety_issue": "No", 
                "time_frame": "Duration of hospital stay, an expected average of 3 weeks"
            }, 
            {
                "description": "Will compare pediatric multiple organ dysfunction scores (PMODS) throughout hospitalization", 
                "measure": "Organ Dysfunction", 
                "safety_issue": "No", 
                "time_frame": "Duration of hospital stay, an expected average of 3 weeks"
            }, 
            {
                "description": "Will assess TISS-28 scores throughout hospitalization.", 
                "measure": "Patient acuity", 
                "safety_issue": "No", 
                "time_frame": "Duration of hospital stay, an expected average of 3 weeks"
            }
        ], 
        "source": "Phoenix Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Phoenix Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}